Healthstream (HSTM) Cash from Financing Activities (2016 - 2025)
Healthstream (HSTM) has disclosed Cash from Financing Activities for 16 consecutive years, with -$7.2 million as the latest value for Q4 2025.
- On a quarterly basis, Cash from Financing Activities fell 601.26% to -$7.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$36.3 million, a 703.08% decrease, with the full-year FY2025 number at -$36.3 million, down 703.08% from a year prior.
- Cash from Financing Activities was -$7.2 million for Q4 2025 at Healthstream, up from -$7.9 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of -$20000.0 in Q3 2022 to a low of -$20.2 million in Q1 2022.
- A 5-year average of -$4.4 million and a median of -$1.7 million in 2024 define the central range for Cash from Financing Activities.
- Peak YoY movement for Cash from Financing Activities: skyrocketed 99.18% in 2022, then crashed 17502.13% in 2023.
- Healthstream's Cash from Financing Activities stood at -$5.7 million in 2021, then surged by 99.18% to -$47000.0 in 2022, then plummeted by 17502.13% to -$8.3 million in 2023, then skyrocketed by 87.51% to -$1.0 million in 2024, then plummeted by 601.26% to -$7.2 million in 2025.
- Per Business Quant, the three most recent readings for HSTM's Cash from Financing Activities are -$7.2 million (Q4 2025), -$7.9 million (Q3 2025), and -$19.1 million (Q2 2025).